Full Name
Jianbiao Zhou
Variants
Zhou J.
Zhou, J.
Zhou, J.B.
Zhou J
Zhou Jianbiao
Zhou, Jianbiao
 
 
 
Email
csizjb@nus.edu.sg
 

Publications

Refined By:
Department:  MEDICINE
Department:  CANCER SCIENCE INSTITUTE OF SINGAPORE
Department:  DEAN'S OFFICE (MEDICINE)

Results 1-20 of 27 (Search time: 0.014 seconds).

Issue DateTitleAuthor(s)
12018A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphataseZhou, J ; Toh, S.H.-M; Chan, Z.-L; Quah, J.Y; Chooi, J.-Y ; Tan, T.Z ; Chong, P.S.Y ; Zeng, Q ; Chng, W.-J 
22015Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: From molecular pathogenesis to therapeutic targetZhou J. ; Ching Y.Q. ; Chng W.-J. 
31-Mar-2011Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profilingNg, Siok-Bian ; Selvarajan, Viknesvaran; Huang, Gaofeng; Zhou, Jianbiao ; Feldman, Andrew L; Law, Mark; Kwong, Yok-Lam; Shimizu, Norio; Kagami, Yoshitoyo; Aozasa, Katsuyuki; Salto-Tellez, Manuel; Chng, Wee-Joo 
41-Sep-2020ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia.Zhou, Jianbiao ; Yiying Quah, Jessie ; Ng, Yvonne ; Chooi, Jing-Yuan ; Hui-Min Toh, Sabrina ; Lin, Baohong; Zea Tan, Tuan ; Hosoi, Hiroki ; Osato, Motomi ; Seet, Qihui; Ooi, Lisa AG; Lindmark, Bertil; McHale, Mark; Chng, Wee-Joo 
511-Jul-2018BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemiaZhou Y.; Zhou J. ; Lu X.; Tan T.-Z. ; Chng W.-J. 
61-Mar-2022Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple MyelomaZhou, Jianbiao ; Chng, Wee-Joo 
718-Feb-2021Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myelomaXiong, Sinan; Chng, Wee-Joo ; Zhou, Jianbiao 
82009Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AMLZhou, J. ; Bi, C.; Janakakumara, J.V. ; Liu, S.-C.; Chng, W.-J. ; Tay, K.-G. ; Poon, L.-F. ; Xie, Z. ; Palaniyandi, S. ; Chen, C.-S. ; Yu, H. ; Glaser, K.B.; Albert, D.H.; Davidsen, S.K.
92015Functional characterization of D9, a novel deazaneplanocin a (DZNep) analog, in targeting acute myeloid leukemia (AML)Jiang, Xia; Lim, Cheryl Zi Hui; Li, Zhimei; Lee, Puayleng; Yatim, Siti Maryam J. M.; Guan, Peiyong; Li, Juntao; Zhou, Jianbiao ; Pan, Jingxuan; Chng, Wee Joo ; Chai, Li Lin Christina ; Yu, Qiang 
102015Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaBi, C; Chung, T.-H ; Huang, G ; Zhou, J ; Yan, J ; Ahmann, G.J; Fonseca, R; Chng, W.J 
1115-Sep-2019IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple MyelomaChong, Phyllis SY ; Zhou, Jianbiao ; Lim, Julia SL ; Hee, Yan Ting; Chooi, Jing-Yuan ; Chung, Tae-Hoon ; Tan, Zea Tuan ; Zeng, Qi ; Waller, Daniel D; Sebag, Michael; Chng, Wee-Joo 
122017Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemiaZhou, J ; Bi, C; Ching, Y.Q ; Chooi, J.-Y ; Lu, X; Quah, J.Y ; Toh, S.H.-M ; Chan, Z.-L; Tan, T.Z ; Chong, P.S ; Chng, W.-J 
131-Mar-2017LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AMLZhou, Jianbiao ; Chan, Zit-Liang; Bi, Chonglei; Lu, Xiao; Chong, Phyllis SY ; Chooi, Jing-Yuan ; Cheong, Lip-Lee; Liu, Shaw-Cheng; Ching, Ying Qing ; Zhou, Yafeng; Osato, Motomi; Tan, Tuan Zea ; Ng, Chin Hin ; Ng, Siok-Bian ; Wang, Shi ; Zeng, Qi ; Chng, Wee-Joo 
1426-Apr-2018NF-kappa B promotes the stem-like properties of leukemia cells by activation of LIN28BZhou, Jianbiao ; Chooi, Jing-Yuan ; Ching, Ying Qing ; Quah, Jessie Yiying ; Toh, Sabrina Hui-Min ; Ng, Yvonne ; Tan, Tuan Zea ; Chng, Wee-Joo 
1528-Feb-2019Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemiaChong, Phyllis SY ; Zhou, Jianbiao ; Chooi, Jing-Yuan ; Chan, Zit-Liang; Toh, Sabrina Hui Min ; Tan, Tuan Zea ; Wee, Sheena; Gunaratne, Jayantha ; Zeng, Qi ; Chng, Wee-Joo 
1624-Sep-2019Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma.Zhou, Jianbiao ; Chng, Wee-Joo 
172015P53 mutations in colorectal cancer- Molecular pathogenesis and pharmacological reactivationLi X.-L; Zhou J ; Chen Z.-R; Chng W.J 
1813-Jul-2010PCBP1 Suppresses the Translation of Metastasis-Associated PRL-3 PhosphataseWang, Haihe; Vardy, Leah A; Tan, Cheng Peow; Loo, Jia Min; Guo, Ke; Li, Jie; Lim, Seng Gee ; Zhou, Jianbiao ; Chng, Wee Joo ; Ng, Siok Bian ; Li, Hui Xiang; Zeng, Qi
192015PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanismsLi, X.-L; Zhou, J ; Chan, Z.-L; Chooi, J.-Y ; Chen, Z.-R; Chng, W.-J 
202019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q.